Antiplatelets Are Enough for Nondisabling Strokes

This Viewpoint argues, in keeping with current stroke management guidelines, that patients with mild, nondisabling strokes should not receive thrombolysis, even when presenting within the time window for treatment.

Saved in:
Bibliographic Details
Published inArchives of neurology (Chicago) Vol. 80; no. 12; p. 1263
Main Authors Braksick, Sherri A, Rabinstein, Alejandro A
Format Journal Article
LanguageEnglish
Published United States American Medical Association 01.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This Viewpoint argues, in keeping with current stroke management guidelines, that patients with mild, nondisabling strokes should not receive thrombolysis, even when presenting within the time window for treatment.
ISSN:2168-6149
2168-6157
DOI:10.1001/jamaneurol.2023.3994